v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net earnings/(loss) $ 556 $ 454
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 247 233
Gain (Loss) on Sale of Investments 16 5
Equity Method Investment, Realized Gain (Loss) on Disposal (2) 0
Impairments and (gain)/loss on disposal of assets, net (4) 2
Share-based compensation 109 93
Provision for bad debts 14 13
Change in operating assets and liabilities, net of effects from acquisitions and divestitures:    
Increase in trade receivables (734) (539)
Increase in inventories (1,171) (736)
Increase in accounts payable 2,653 2,147
Other accrued liabilities and operating items, net (282) (683)
Net cash provided by operating activities 1,398 973
Cash flows from investing activities:    
Payments to Acquire Businesses, Net of Cash Acquired (149) (41)
Additions to property and equipment (157) (108)
Proceeds from sale of available-for-sale securities and other investments 34 9
Proceeds from Sale of Property, Plant, and Equipment 15 0
Increase (decrease) in other investing items, net 6 (2)
Net cash used in investing activities (251) (142)
Cash flows from financing activities:    
Proceeds from Debt, Net of Issuance Costs 0 989
Repayments of Long-term Debt 11 512
Payments to Noncontrolling Interests 3 3
Net tax withholding from share-based compensation (102) (80)
Dividends on common shares (126) (129)
Purchase of treasury shares (500) (375)
Net cash used in financing activities (742) (110)
Effect of exchange rates changes on cash and equivalents 3 (2)
Net increase in cash and equivalents 408 719
Cash and equivalents at beginning of period 4,856 3,874
Cash and equivalents at end of period 5,264 4,593
Repurchases of liability-classified units $ (4) $ (16)